Factorial designs with time to event endpoints

Handbook of Statistics in Clinical Oncology: Second Edition

Volumn , Issue , 2005, Pages 181-189

  Green, Stephanie ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123815978     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (18)

1. McAlister, F., Straus, S., Sackett, D., and Altman D. Analysis and reporting of factorial trials: a systematic review. J. Am. Medical Asso., 289, 2545-2553, 2003.
2. Slud, E. Analysis of factorial survival experiments. Biometrics, 50, 25-38, 1994.
3. Byar, J. Factorial and reciprocal control design. Stat. Med., 9, 55-64,1990.
4. Simon, R. and Freedman L. Bayesian design and analysis of two X two factorial clinical trials. Biometrics, 53, 456-164, 1997.
5. Hung, H. Two-stage tests for studying monotherapy and combination therapy in two-by-two factorial trials. Stat. Med., 12, 645-660, 1993.
6. Hung, H. Evaluation of a combination drug with multiple doses in unbalanced factorial design clinical trials. Stat. Med., 19, 2079-2087, 2000.
7. Akritas, M. and Brunner, E. Nonparametric methods for factorial designs with censored data. J. Am. Stat. Assoc., 92, 568-576, 1997.
8. Green, S., Liu, P.Y., and O'Sullivan, J. Factorial design considerations. J. Clin. Oncology, 20, 3424-3430, 2002.
9. Gail M., et al. Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Sandong, China: design issues and initial data. Controlled Clin. Trials, 19, 352-369, 1998.
10. Miller, T. et al. A randomized trial of chemotherapy and radiotherapy for stage III non-small cell lung cancer. Cancer Therapeutics, 1, 229-236, 1998.
11. Dunnet, C. A multiple comparisons procedure for comparing several treatments with a control. J. Am. Stat. Assoc., 60, 573-583, 1955.
12. Marcus, R., Peritz, E., and Gabriel K. On closed testing procedures with special reference to ordered analysis of variance. Biometrika, 63, 655-660, 1976.
13. Tang, D.-I. and Lin, S. An approximate likelihood ratio test for comparing several treatments to a control. J. Am. Stat. Assoc., 92, 1155-1162, 1997.
14. Liu, P.Y. and Dahlberg, S. Design and analysis of multiarm clinical trials with survival endpoints. Controlled Clin. Trials, 16,119-130, 1995.
15. Liu, P.Y., Tsai, W.Y., and Wolf M. Design and analysis for survival data under order restrictions with a modified logrank test. Stat. Med., 17, 1469-1479, 1998.
16. Chen, T. and Simon, R. Extension of one-sided test to multiple treatment trials. Controlled Clin. Trials, 15, 124-134, 1994.
17. Gandara, D. et al. Evaluation of cisplatin in metastatic non-small cell lung cancer: a Phase III study of the Southwest Oncology Group. J. Clin. Oncology, 11, 873-878, 1993.
18. Peterson, B. and George, S. Sample size requirements and length of study for testing interaction in a 2 X K factorial design when time to failure is the outcome. Controlled Clin. Trials, 14, 511-522, 1993.